The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

To the Editor: We appreciate the insightful (no pun intended!) comments on our recent publication examining the relationship between violence, psychopathology, and insight in schizophrenia by Mr. Antonius. His point regarding the differential severity of illness across treatment settings is well taken, and we agree that an acute or long-term inpatient comparison group may have been more apt. He concurs with our statement that research on this patient population is difficult to conduct and, consequently, the population is underrepresented in the psychiatric literature. Because our article was limited in scope by the Brief Report format, we are pleased that the citations of Mr. Antonius in this correspondence further detail the literature on this topic. We have provided more lengthy discussions on the medical-legal implications of lack of insight and the treatment implications thereof in other publications (1).

Reference

1. Buckley PF, Wirshing DA, Pierre J, Bushan P, Resnick S, Wirshing WC: Lack of insight and treatment adherence in schizophrenia. CNS Drugs (in press)Google Scholar